It’s time to rethink the physician-pharma relationship
The traditional sales channel for the pharmaceutical industry has centered on face-to-face interaction with its core target audience – prescribing [...]
What does the future of European healthcare look like?
After the “stress test” of COVID, how can the sector create resilient, sustainable healthcare systems for the long term? COVID [...]
Joe Biden’s HHS Secretary Has the Power to Lower Drug Prices. He Isn’t Using It
Joe Biden's HHS Secretary Has the Power to Lower Drug Prices. He Isn't Using It Candidate Joe Biden promised to [...]
United States: FDA Acting Commissioner Of Food And Drugs Seeks Collaboration Between FDA And USPTO To Address Pharmaceutical Patent-Related Matters Affecting Competition – Haug Partners
On September 10, 2021, Janet Woodcock, Acting Commissioner of the U.S. Food and Drug Administration (FDA), sent a letter to [...]
Kaiser Family Foundation: Public not buying pharma’s arguments over drug price reforms
A vast majority of the public rejected a common argument from the pharmaceutical industry that high drug prices are needed [...]
Ipsen appoints Mari Scheiffele as EVP and President, Specialty Care International
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) announced today the appointment of Mari Scheiffele as EVP and President, Specialty [...]
Syntropy and UCI Unite in 5-Year RWD Collaboration to Improve Patient Outcomes
Syntropy and the University of California, Irvine (UCI) will collaborate in a five-year partnership intended to directly improve patient outcomes [...]
PRMA Consulting Leader Discusses the Rapidly Increasing Influence of ICER’s Value Access Frameworks
Senior Principal at PRMA Consulting Emily Coriale discusses how value assessments put forth by the Institute for Clinical and Economic [...]
PRMA Consulting Senior Advisor Discusses the Four Pillars of Market Access and New Pharma Trends
Senior Advisor, Asia-Pacific at PRMA Consulting Jeff Weisel shared an update to his previous article detailing the four strategic pillars [...]
Three RWD Economists Granted Nobel Prize
Economists David Card, Joshua Angrist, and Guido Imbens were granted the Nobel Prize in Economic Sciences by the Royal Swedish [...]
New Book on Historic and Future Pharma Trends Now Available
A recently published book authored by Mickey C. Smith, PhD details the multi-faceted issues facing pharma and healthcare. Francis B. [...]
5 Up and Coming Biotech Startups Worth Watching
5 Up and Coming Biotech Startups Worth Watching Biotechnology companies aim to develop products and technologies that can solve the [...]
Refining digital collaboration
Pharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to COVID, the [...]
Pfizer CEO—Biden’s ‘Good Friend’—Is Privately Working to Tank Drug Price Reforms
Pfizer CEO—Biden’s ‘Good Friend’—Is Privately Working to Tank Drug Price Reforms Pfizer's chief executive Albert Bourla is reportedly urging his [...]
MAPS Webinar on Considerations for External Research
The Medical Affairs Professional Society (MAPS) has released a webinar detailing considerations for external research studies. The webinar highlights privacy [...]
The Public Weighs In On Medicare Drug Negotiations
The Public Weighs In On Medicare Drug Negotiations Key Findings - With much attention on the public’s view on Medicare [...]
MAPS Releases Whitepaper on Field Medical Metrics and KPIs
The Medical Affairs Professional Society (MAPS) has released a whitepaper detailing how field medical metrics and key performance indicators (KPIs) [...]
Big Pharma is twisting facts to try and convince you that a new plan to lower drug prices would actually be bad. Don’t fall for it.
As reforms make their way through Congress, Big Pharma's ad campaigns are in full swing. The ads are full of [...]
Don’t pass a law that would halt research into new cures
Democratic lawmakers are playing a dangerous game with the lives of seniors as they pursue drug pricing schemes that would [...]
Exclusive AIS Health Data Shows How Much Health Insurer CEOs Were Paid in 2020
Although some health insurers reported record-high profits as the COVID-19 pandemic drove down routine care utilization, that trend did not [...]
ICER Meets With FDA, EMA, and FDA to Discuss RWE Procedures
In a recent meeting, members of the Institute for Clinical and Economic Review (ICER), the Food and Drug Administration (FDA), [...]
CADTH Welcomes New Members to the Board of Directors
CADTH is pleased to announce the appointment of 4 new members to the CADTH Board of Directors. “I am pleased [...]
ICER’s Value Assessments Inform Pricing Decisions
Although new technologies have brought about novel therapies for previously unaddressed diseases, setting prices for these sometimes life-saving treatments remains [...]
ISPOR 2022 Meeting Seeking Abstracts on RWE and HEOR
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is seeking abstracts for its 2022 meeting, held both in-person and virtually next [...]
Building Data Lakes for Healthcare providers- 2021 Guide and Roadmap | by ResolveData | Oct, 2021 |
Digital transformation improvements have arrived at a time when healthcare organizations are scrambling to increase the efficiency of their electronic [...]